Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of EPZ-6438
Tazemetostat
1403254-99-8
|
572.336
|
3.378
Tazemetostat is a methyltransferase inhibitor indicated to treat patients 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.
E7438 | EPZ-6438 | tazemetostat | tazverik
Tazemetostat is a methyltransferase inhibitor indicated to treat patients 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.
E7438 | EPZ-6438 | tazemetostat | tazverik
$67/5 mg
(EBC)
1
We provide 0 compound for EPZ-6438
